2-[(2-methyl-8-quinolinyl)oxy]ethanamine(SALTDATA: 2.2HCl 0.7H2O)
![]() |
- $63 - $499
- Product name: 2-[(2-methyl-8-quinolinyl)oxy]ethanamine(SALTDATA: 2.2HCl 0.7H2O)
- CAS: 1094492-24-6
- MF: C12H14N2O
- MW: 202.25
- EINECS:
- MDL Number:MFCD11647851
- Synonyms:2-[(2-methyl-8-quinolinyl)oxy]ethanamine(SALTDATA: 2.2HCl 0.7H2O);2-[(2-methyl-8-quinolinyl)oxy]ethanamine(SALTDATA;Ethanamine, 2-[(2-methyl-8-quinolinyl)oxy]-;2-((2-Methylquinolin-8-yl)oxy)ethan-1-amine
4 prices
Selected condition:
Brand
- ChemBridge Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- 200μmol
- ManufacturerChemBridge Corporation
- Product numberBB-4110544
- Product description{2-[(2-methyl-8-quinolinyl)oxy]ethyl}aminedihydrochloride 95%
- Packaging200μmol
- Price$63
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM222653
- Product description2-((2-Methylquinolin-8-yl)oxy)ethanamine 95%
- Packaging5g
- Price$471
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11353305
- Product description2-((2-Methylquinolin-8-yl)oxy)ethanamine 95+%
- Packaging5g
- Price$499
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number060215
- Product description{2-[(2-Methylquinolin-8-yl)oxy]ethyl}aminedihydrochloride
- Packaging500mg
- Price$158
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ChemBridge Corporation | BB-4110544 | {2-[(2-methyl-8-quinolinyl)oxy]ethyl}aminedihydrochloride 95% | 200μmol | $63 | 2021-12-16 | Buy |
Chemenu | CM222653 | 2-((2-Methylquinolin-8-yl)oxy)ethanamine 95% | 5g | $471 | 2021-12-16 | Buy |
Crysdot | CD11353305 | 2-((2-Methylquinolin-8-yl)oxy)ethanamine 95+% | 5g | $499 | 2021-12-16 | Buy |
Matrix Scientific | 060215 | {2-[(2-Methylquinolin-8-yl)oxy]ethyl}aminedihydrochloride | 500mg | $158 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|